Iron Deficiency Anemia Clinical Trial
Official title:
The Effect of Yoga Breathing Exercises Versus Aerobic Exercise on Hematological Parameters in Iron Deficiency Anemic Females
Is there effect of yoga breathing exercises versus aerobic exercise on hematological parameters in iron deficiency anemic females? The purpose of the study is to investigate the effect of yoga breathing exercises versus aerobic exercise on hematological parameters in iron deficiency anemic females
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 1, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 30 Years to 40 Years |
Eligibility | Inclusion Criteria: 1. Sixty female patients referred with iron deficiency anemia 2. Their age will be ranged from 30-40 years old. 3. All patients have a history of anemia. 4. All patients should be medically stable. 5. The body mass index (BMI) ranged from 25:29.9 Kg/m2 6. Number of parity not exceed 3 times. 7. Period of menses from 3-5 days Exclusion Criteria: 1. Patients with cognitive impairments. 2. All types of anemia except iron deficiency anemia 3. patients with hearing problems. 4. patients with Diabetes, Hypertension. 5. Patients with Musculoskeletal, Neurological, Cardiovascular and Respiratory problems 6. patients with mental problems. |
Country | Name | City | State |
---|---|---|---|
Egypt | October 6 university | Giza |
Lead Sponsor | Collaborator |
---|---|
Shokry Mahmoud Youssef Mohamed |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | serum iron level | it will be measured in serum from complete blood picture. Reference range from 50 till 212 ug/dl. Number of participants are 60 females. | it will be measured after 12 weeks | |
Primary | ferritin level | it will be measured in serum from iron profile. Reference range from 10 till 158 ng/ml. Number of participants are 60 females. | it will be measured after 12 weeks | |
Primary | iron binding capacity level | it will be measured in serum from iron profile. Reference range from 250 till 400 ug/dl. Number of participants are 60 females. | it will be measured after 12 weeks | |
Primary | count of red blood cells | it will be measured in serum from complete blood picture. Reference range from 3.80 till 4.80 million cell/cmm. Number of participants are 60 females. | it will be measured after 12 weeks | |
Primary | Hemoglobin level | it will be measured in serum from complete blood . picture. Reference range from 12 till 15 g/dl. Number of participants are 60 females. | it will be measured after 12 weeks | |
Primary | hematocrite level | it will be measured in serum from complete blood picture. Reference range from 36% till 45%. Number of participants are 60 females. | it will be measured after 12 weeks | |
Primary | lymphocytes level | it will be measured in serum from differential white cell count. Reference range absolute from 1000 till 4000 and relative from 20% till 45%. Number of participants are 60 females. | it will be measured after 12 weeks | |
Secondary | six minute walking distance | The six minute walking distance is measured using six Minute Walk Test which is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
The tools are used include 30 meters corridor,2 cones,stopwatch,chair,mechanical lap counter and sphygmomanometer Number of participants are 60 females. |
it will be measured after 12 weeks | |
Secondary | The fatigue severity scale(FSS) | The FSS questionnaire contains nine statements that rate the severity of your fatigue symptoms. Read each statement and circle a number from 1 to 7, based on how accurately it reflects your condition during the past week and the extent to which you agree or disagree that the statement applies to you.
A total score of less than 36 suggests that you may not be suffering from fatigue. A total score of 36 or more suggests that you may need further evaluation by a physician. Number of participants are 60 females. |
it will be measured after 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06027801 -
Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity
|
N/A | |
Completed |
NCT02282553 -
Gastric Capsule Examination for Iron Deficiency Anaemia
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Recruiting |
NCT04913649 -
Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients
|
Phase 4 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Completed |
NCT01307007 -
Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
|
Phase 2 | |
Completed |
NCT00982007 -
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
|
Phase 3 | |
Completed |
NCT00198848 -
Iron Supplementation Among Adolescent Girls in India
|
N/A | |
Completed |
NCT01166451 -
The Anemia Control Program: High or Low Iron Supplementation
|
N/A | |
Recruiting |
NCT03893045 -
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
|
Phase 3 | |
Recruiting |
NCT03817957 -
Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency
|
Phase 3 | |
Completed |
NCT03819530 -
Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study
|
N/A | |
Completed |
NCT03618914 -
Anemia and Inflammation
|
||
Completed |
NCT03940430 -
Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students
|
Phase 2/Phase 3 | |
Withdrawn |
NCT03873584 -
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
|
||
Enrolling by invitation |
NCT03897673 -
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas
|
N/A | |
Active, not recruiting |
NCT04778072 -
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
|
N/A | |
Completed |
NCT03237065 -
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
|
Phase 3 | |
Completed |
NCT05153278 -
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
|